Improving cancer care access and outcomes through patient navigation
PARTNERS: Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
This study tests a new way to help people newly diagnosed with cancer get better access to care and support, especially for those who might not have the same resources.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 375 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Case Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT06481774 on ClinicalTrials.gov |
What this trial studies
This research evaluates a novel approach to providing patient navigation services aimed at enhancing cancer outcomes and quality of life for individuals newly diagnosed with cancer. The study focuses on integrating navigational processes to ensure timely and equitable access to cancer care, particularly for underserved populations. By leveraging the CONNECT platform, the initiative seeks to address disparities in cancer service delivery based on social determinants of health. The study is part of a national effort to create a sustainable model for equitable cancer care services.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have had a suspicious cancer screening finding or are referred to a diagnostic clinic, particularly those identifying as African American, Hispanic, or residing in high-need geographic areas.
Not a fit: Patients who do not have a suspicious cancer screening finding or are not willing to complete an informed consent form may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve cancer care access and outcomes for underserved populations.
How similar studies have performed: Other studies have shown success with patient navigation approaches in improving cancer care access and outcomes, making this initiative a continuation of established practices.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: There are two levels of criteria for inclusion. * First, investigators will identify individuals who have either had a cancer screening with a suspicious finding (ie. requires diagnostic follow-up) or those individuals who are referred to the UH Seidman Diagnostic Clinic (led by Co-I Hoehn). * Within that group, investigators will recruit those who identify as African American, Hispanic, or living in a prioritized geography as defined by zip code ADI\>=75%ile for state Exclusion Criteria: * Any participant who is not willing or able to complete an informed consent form will not be eligible for this study
Where this trial is running
Cleveland, Ohio
- Case Comprehensive Cancer Center — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Erika Trapl, PhD — Case Western Reserve University, Case Comprehensive Cancer Center
- Study coordinator: Erika Trapl, PhD
- Email: erika.trapl@case.edu
- Phone: 216-368-0098
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.